Canada Spends Logo

Explorez notre analyse du budget 2026

Grant: CIHR Café Scientifique Program

Queen's University (Kingston, Ontario)

$3,000.00

Glaucoma: The Silent Thief Of Vision. Understanding Optic Neuropathies and Associated Vision Loss

EF 2011-12

Résumé
Glaucoma refers to a group of eye diseases that are characterized by damage to the optic nerve at the back of the eye, causing permanent vision loss. It is the leading cause of irreversible blindness worldwide. Disease progression is typically painless and unnoticeable until a significant reduction in vision occurs. As such,glaucoma is often referred to as the silent thief of vision. The exact causes of glaucoma are not well understood. However, several risk factors have been identified including age, family history, and elevated pressure within the eye (intraocular pressure), the latter being the major modifiable risk factor. Once an ophthalmologist has given the diagnosis of glaucoma, the typical first line of treatment consists of eye drops to lower the intraocular pressure. At times, a person may be using multiple different types of drops to effectively lower pressure. Laser treatment or surgical options are sometimes necessary. Surgery involves making an alternate drainage system for the fluid in the eye and is usually performed when medications and lasers are inadequate. There is no cure for glaucoma and slowing vision loss in patients with glaucoma requires a dedicated and cooperative effort from the patient and a long term, committed relationship with their eye care professional. This Café Scientifique will provide an excellent forum to disseminate information regarding the facts about Glaucoma. It will serve to address a need in the community for patient education on a disease that is largely painless and asymptomatic until significant vision has been permanently lost. Important questions that will be addressed during the course of the Café will include: What is Glaucoma? What are the different types of Glaucoma? What causes Glaucoma? How is Glaucoma diagnosed? How is Glaucoma treated? Are there new treatment options being developed for Glaucoma?
Programme
CIHR Café Scientifique Program
Emplacement
Ontario, Canada
Type
Grant
Source
CIHR Funding Decisions Database

Tel que publié

Id
236742
Name
Irrcher Isabella
Region
Ontario
Country
Canada
Orgtype
Institution Paid; Research Institution
Instname2
Aging
Theme2
Social / Cultural / Environmental / Population Health
Prcname2
CIHR Café Scientifique Program
Projecttitle
Glaucoma: The Silent Thief Of Vision. Understanding Optic Neuropathies and Associated Vision Loss
Programtype2
Miscellaneous Programs
Orgnameinp2
Queen's University (Kingston, Ontario)
Cihramount2
$3,000
Cihrequipment2
$0
Programname2
CIHR Café Scientifique Program
Keyworddelim
Blindess; Glaucoma; Optic Neuropathy; Retinal Ganglion Cell Death
Abstract
Glaucoma refers to a group of eye diseases that are characterized by damage to the optic nerve at the back of the eye, causing permanent vision loss. It is the leading cause of irreversible blindness worldwide. Disease progression is typically painless and unnoticeable until a significant reduction in vision occurs. As such,glaucoma is often referred to as the silent thief of vision. The exact causes of glaucoma are not well understood. However, several risk factors have been identified including age, family history, and elevated pressure within the eye (intraocular pressure), the latter being the major modifiable risk factor. Once an ophthalmologist has given the diagnosis of glaucoma, the typical first line of treatment consists of eye drops to lower the intraocular pressure. At times, a person may be using multiple different types of drops to effectively lower pressure. Laser treatment or surgical options are sometimes necessary. Surgery involves making an alternate drainage system for the fluid in the eye and is usually performed when medications and lasers are inadequate. There is no cure for glaucoma and slowing vision loss in patients with glaucoma requires a dedicated and cooperative effort from the patient and a long term, committed relationship with their eye care professional. This Café Scientifique will provide an excellent forum to disseminate information regarding the facts about Glaucoma. It will serve to address a need in the community for patient education on a disease that is largely painless and asymptomatic until significant vision has been permanently lost. Important questions that will be addressed during the course of the Café will include: What is Glaucoma? What are the different types of Glaucoma? What causes Glaucoma? How is Glaucoma diagnosed? How is Glaucoma treated? Are there new treatment options being developed for Glaucoma?
Competitiondate
201106
Approvedterm2
1 yr 0 mth
Pinamesdelim
Irrcher, Isabella; Campbell, Robert J; El-Defrawy, Sherif R; Jinapriya, Delan
Approvedterm
1 an 0 mois
Cihrcontribution2
Knowledge Translation Branch~ $3,000~ $0~